Qube Research & Technologies »

Autolus Therapeutics Plc spon ads shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.8M 802k 3.48
2024-03-31 $310k 49k 6.38
2023-09-30 $24k 10k 2.33
2023-06-30 $52k 22k 2.38

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Visa Com Cl A (V)
Microsoft Corporation (MSFT)
Intel Corporation (INTC)
Meta Platforms Cl A (META)
Merck & Co (MRK)
Accenture Plc Ireland Shs Class A (ACN)
Lam Research Corporation (LRCX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amgen (AMGN)
Adobe Systems Incorporated (ADBE)
NVIDIA Corporation (NVDA)

View all positions for Qube Research & Technologies

Top funds holding Autolus Therapeutics Plc spon ads

Syncona Portfolio
Blackstone Group
Deep Track Capital
Polygon Management
Armistice Capital
Frazier Life Sciences Management
Affinity Asset Advisors
BlackRock
BlackRock
T. Rowe Price Associates
Deerfield Management Company
Laurion Capital Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Stempoint Capital

View all funds holding Autolus Therapeutics Plc spon ads